Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1992 1
1994 2
1995 2
1996 2
1997 1
1998 2
1999 2
2000 3
2004 2
2007 2
2009 3
2010 3
2011 7
2012 6
2013 2
2014 7
2015 5
2016 5
2017 10
2018 6
2019 7
2020 6
2021 9
2022 4
Text availability
Article attribute
Article type
Publication date

Search Results

93 results
Results by year
Filters applied: . Clear all
Page 1
Cystic fibrosis year in review 2016.
Savant AP, McColley SA. Savant AP, et al. Among authors: mccolley sa. Pediatr Pulmonol. 2017 Aug;52(8):1092-1102. doi: 10.1002/ppul.23747. Epub 2017 Jun 13. Pediatr Pulmonol. 2017. PMID: 28608632 Review.
Diagnosis of Cystic Fibrosis: Consensus Guidelines from the Cystic Fibrosis Foundation.
Farrell PM, White TB, Ren CL, Hempstead SE, Accurso F, Derichs N, Howenstine M, McColley SA, Rock M, Rosenfeld M, Sermet-Gaudelus I, Southern KW, Marshall BC, Sosnay PR. Farrell PM, et al. Among authors: mccolley sa. J Pediatr. 2017 Feb;181S:S4-S15.e1. doi: 10.1016/j.jpeds.2016.09.064. J Pediatr. 2017. PMID: 28129811 Free article.
Cystic fibrosis year in review 2018, part 1.
Savant AP, McColley SA. Savant AP, et al. Among authors: mccolley sa. Pediatr Pulmonol. 2019 Aug;54(8):1117-1128. doi: 10.1002/ppul.24361. Epub 2019 May 20. Pediatr Pulmonol. 2019. PMID: 31106528 Review.
Lumacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR.
Wainwright CE, Elborn JS, Ramsey BW, Marigowda G, Huang X, Cipolli M, Colombo C, Davies JC, De Boeck K, Flume PA, Konstan MW, McColley SA, McCoy K, McKone EF, Munck A, Ratjen F, Rowe SM, Waltz D, Boyle MP; TRAFFIC Study Group; TRANSPORT Study Group. Wainwright CE, et al. Among authors: mccolley sa. N Engl J Med. 2015 Jul 16;373(3):220-31. doi: 10.1056/NEJMoa1409547. Epub 2015 May 17. N Engl J Med. 2015. PMID: 25981758 Free PMC article. Clinical Trial.
A Phase 3 Open-Label Study of Elexacaftor/Tezacaftor/Ivacaftor in Children 6 through 11 Years of Age with Cystic Fibrosis and at Least One F508del Allele.
Zemanick ET, Taylor-Cousar JL, Davies J, Gibson RL, Mall MA, McKone EF, McNally P, Ramsey BW, Rayment JH, Rowe SM, Tullis E, Ahluwalia N, Chu C, Ho T, Moskowitz SM, Noel S, Tian S, Waltz D, Weinstock TG, Xuan F, Wainwright CE, McColley SA. Zemanick ET, et al. Among authors: mccolley sa. Am J Respir Crit Care Med. 2021 Jun 15;203(12):1522-1532. doi: 10.1164/rccm.202102-0509OC. Am J Respir Crit Care Med. 2021. PMID: 33734030 Free PMC article. Clinical Trial.
Cystic fibrosis year in review 2017.
Savant AP, McColley SA. Savant AP, et al. Among authors: mccolley sa. Pediatr Pulmonol. 2018 Sep;53(9):1307-1317. doi: 10.1002/ppul.24081. Epub 2018 Jun 21. Pediatr Pulmonol. 2018. PMID: 29927544 Review.
This issue: pulmonology.
McColley SA. McColley SA. Pediatr Ann. 2010 Dec;39(12):742-4. doi: 10.3928/00904481-20101116-02. Pediatr Ann. 2010. PMID: 21162480 No abstract available.
Comment on Munck et al., Feb, 2021.
Sontag MK, Farrell PM, Kellar-Guenther Y, Martiniano SL, Miller JI, Ren CL, McColley SA. Sontag MK, et al. Among authors: mccolley sa. J Cyst Fibros. 2021 Jul;20(4):717-718. doi: 10.1016/j.jcf.2021.04.003. Epub 2021 May 19. J Cyst Fibros. 2021. PMID: 34020895 No abstract available.
The demographics of adverse outcomes in cystic fibrosis.
McGarry ME, Williams WA 2nd, McColley SA. McGarry ME, et al. Among authors: mccolley sa. Pediatr Pulmonol. 2019 Nov;54 Suppl 3(Suppl 3):S74-S83. doi: 10.1002/ppul.24434. Pediatr Pulmonol. 2019. PMID: 31715087 Free PMC article. Review.
Designing trials for new cystic fibrosis modulators.
Cunningham S, McColley SA. Cunningham S, et al. Among authors: mccolley sa. Lancet Respir Med. 2018 Jul;6(7):484-486. doi: 10.1016/S2213-2600(18)30195-4. Epub 2018 May 31. Lancet Respir Med. 2018. PMID: 29859920 Review. No abstract available.
93 results